Qpex Biopharma, Inc. — Form D/A
Qpex Biopharma, Inc. of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2019-08-01. The offering totals $41.1M, of which $27.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-08-01
- Form: D/A
- Accession: 0001755902-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $41.1M
- Amount sold: $27.4M
- Remaining: $13.7M
- Investors: 11
- Date of first sale: 2018-10-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-323670
Issuer
- Name: Qpex Biopharma, Inc.
- CIK: 0001755902
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 6275 Nancy Ridge Drive, SAN DIEGO, CA, 92121
- Phone: 858-774-7361
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Daniel N Burgess | Director | San Diego, CA |
| Michael N Dudley | Director | San Diego, CA |
| Carol N Gallagher | Director | San Diego, CA |
| Terry N Gould | Director | San Diego, CA |
| Kevin N Li | Director | San Diego, CA |
| Douglas N Reed | Director | San Diego, CA |
| Michael N Dudley | Executive Officer | San Diego, CA |
Other filings by this issuer (1)
More